Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.23.1
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Product revenue, net $ 12,165 $ 20,796
Collaboration revenue 181 577
Revenue - related party 35 52
Other revenue 48 2,500
Net revenue 12,429 23,925
Qbrexza    
Product revenue, net 4,094 7,376
Other revenue 2,500  
Accutane    
Product revenue, net 4,648 4,907
Amzeeq    
Product revenue, net 1,193 3,466
Targadox    
Product revenue, net 793 2,634
Ximino    
Product revenue, net 612 967
Zilxi    
Product revenue, net 314 741
Exelderm    
Product revenue, net $ 511 704
Other Branded Revenue    
Product revenue, net   $ 1